Vaccine adjuvants have evolved significantly since their inception, transitioning from empirical discovery to a more structured approach grounded in rational drug design.
Longeveron scores RMAT designation for Alzheimer’s cell therapy
Longeveron’s Lomecel-B is made up of human mesenchymal stem cells, derived from the bone marrow of healthy human donors. Image Credit: Berit Kessler / Shutterstock.